Cargando…

Natural Bioactive Products as Epigenetic Modulators for Treating Neurodegenerative Disorders

Neurodegenerative disorders (NDDs) are major health issues in Western countries. Despite significant efforts, no effective therapeutics for NDDs exist. Several drugs that target epigenetic mechanisms (epidrugs) have been recently developed for the treatment of NDDs, and several of these are currentl...

Descripción completa

Detalles Bibliográficos
Autores principales: Martínez-Iglesias, Olaia, Naidoo, Vinogran, Carrera, Iván, Corzo, Lola, Cacabelos, Ramón
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9967112/
https://www.ncbi.nlm.nih.gov/pubmed/37259364
http://dx.doi.org/10.3390/ph16020216
_version_ 1784897184074825728
author Martínez-Iglesias, Olaia
Naidoo, Vinogran
Carrera, Iván
Corzo, Lola
Cacabelos, Ramón
author_facet Martínez-Iglesias, Olaia
Naidoo, Vinogran
Carrera, Iván
Corzo, Lola
Cacabelos, Ramón
author_sort Martínez-Iglesias, Olaia
collection PubMed
description Neurodegenerative disorders (NDDs) are major health issues in Western countries. Despite significant efforts, no effective therapeutics for NDDs exist. Several drugs that target epigenetic mechanisms (epidrugs) have been recently developed for the treatment of NDDs, and several of these are currently being tested in clinical trials. Furthermore, various bioproducts have shown important biological effects for the potential prevention and treatment of these disorders. Here, we review the use of natural products as epidrugs to treat NDDs in order to explore the epigenetic effects and benefits of functional foods and natural bioproducts on neurodegeneration.
format Online
Article
Text
id pubmed-9967112
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-99671122023-02-26 Natural Bioactive Products as Epigenetic Modulators for Treating Neurodegenerative Disorders Martínez-Iglesias, Olaia Naidoo, Vinogran Carrera, Iván Corzo, Lola Cacabelos, Ramón Pharmaceuticals (Basel) Review Neurodegenerative disorders (NDDs) are major health issues in Western countries. Despite significant efforts, no effective therapeutics for NDDs exist. Several drugs that target epigenetic mechanisms (epidrugs) have been recently developed for the treatment of NDDs, and several of these are currently being tested in clinical trials. Furthermore, various bioproducts have shown important biological effects for the potential prevention and treatment of these disorders. Here, we review the use of natural products as epidrugs to treat NDDs in order to explore the epigenetic effects and benefits of functional foods and natural bioproducts on neurodegeneration. MDPI 2023-01-31 /pmc/articles/PMC9967112/ /pubmed/37259364 http://dx.doi.org/10.3390/ph16020216 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Martínez-Iglesias, Olaia
Naidoo, Vinogran
Carrera, Iván
Corzo, Lola
Cacabelos, Ramón
Natural Bioactive Products as Epigenetic Modulators for Treating Neurodegenerative Disorders
title Natural Bioactive Products as Epigenetic Modulators for Treating Neurodegenerative Disorders
title_full Natural Bioactive Products as Epigenetic Modulators for Treating Neurodegenerative Disorders
title_fullStr Natural Bioactive Products as Epigenetic Modulators for Treating Neurodegenerative Disorders
title_full_unstemmed Natural Bioactive Products as Epigenetic Modulators for Treating Neurodegenerative Disorders
title_short Natural Bioactive Products as Epigenetic Modulators for Treating Neurodegenerative Disorders
title_sort natural bioactive products as epigenetic modulators for treating neurodegenerative disorders
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9967112/
https://www.ncbi.nlm.nih.gov/pubmed/37259364
http://dx.doi.org/10.3390/ph16020216
work_keys_str_mv AT martineziglesiasolaia naturalbioactiveproductsasepigeneticmodulatorsfortreatingneurodegenerativedisorders
AT naidoovinogran naturalbioactiveproductsasepigeneticmodulatorsfortreatingneurodegenerativedisorders
AT carreraivan naturalbioactiveproductsasepigeneticmodulatorsfortreatingneurodegenerativedisorders
AT corzolola naturalbioactiveproductsasepigeneticmodulatorsfortreatingneurodegenerativedisorders
AT cacabelosramon naturalbioactiveproductsasepigeneticmodulatorsfortreatingneurodegenerativedisorders